BIOMAT Database Logo BIOMAT Database Logo

An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma. 1994

H I Scher

UI MeSH Term Description Entries
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016597 Trimetrexate A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against PNEUMOCYSTIS PNEUMONIA in AIDS patients. Myelosuppression is its dose-limiting toxic effect. CI-898,JB-11,NSC-249008,NSC-328564,Trimetrexate Hydrate,Trimetrexate Monohydrate, Monoacetate,CI 898,CI898,Hydrate, Trimetrexate,JB 11,JB11,Monohydrate, Monoacetate Trimetrexate,NSC 249008,NSC 328564,NSC249008,NSC328564

Related Publications

H I Scher
An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma.
February 1994, Cancer,
H I Scher
Phase II trial of trimetrexate for patients with advanced gastric carcinoma: an Eastern Cooperative Oncology Group study (E1287).
August 1999, Cancer,
H I Scher
Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma.
February 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
H I Scher
Phase II trial of PCNU in advanced colorectal carcinoma. An Eastern Cooperative Oncology Group pilot study.
August 1984, American journal of clinical oncology,
H I Scher
Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: an Eastern Cooperative Oncology Group study.
May 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
H I Scher
Phase II trial of trimetrexate in untreated advanced gastric carcinoma. A Southwest Oncology Group study.
January 1994, Investigational new drugs,
H I Scher
A phase II trial of edatrexate in patients with advanced renal cell carcinoma. An Eastern Cooperative Oncology Group study.
June 1997, American journal of clinical oncology,
H I Scher
Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
October 1986, Cancer treatment reports,
H I Scher
Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot study.
January 1985, Investigational new drugs,
H I Scher
Phase 2 trial of sorafenib in patients with advanced urothelial cancer: a trial of the Eastern Cooperative Oncology Group.
September 2009, Cancer,
Copied contents to your clipboard!